Scilex Holding (SCLX) Inventory Average (2023 - 2026)
Scilex Holding (SCLX) recorded quarterly Inventory Average of $4.7 million in Q1 2026, up 58.76% quarter-over-quarter from $2.9 million in Q4 2025, and up 70.93% on a YoY basis from $2.7 million in Q1 2025.
Scilex Holding (SCLX) Inventory Average (2023 - 2026) Analysis & Trends
Scilex Holding's Inventory Average history runs 4 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Inventory Average rose 70.93% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 70.93% YoY), while the FY2025 annual figure was $3.6 million, up 8.65% from the prior year.
- Inventory Average was $4.7 million for Q1 2026 at Scilex Holding, up from $2.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $4.7 million in Q1 2026 to a low of $1.8 million in Q3 2025.
- Historically, Inventory Average has averaged $3.0 million across 4 years, with a median of $2.8 million in 2025.
- Biggest YoY gain for Inventory Average was 110.79% in 2024; the steepest drop was 40.66% in 2024.
- A 4-year view of Inventory Average shows it stood at $4.1 million in 2023, then slumped by 40.66% to $2.4 million in 2024, then advanced by 21.3% to $2.9 million in 2025, then surged by 58.76% to $4.7 million in 2026.
- The last three Inventory Average figures came in at $4.7 million (Q1 2026), $2.9 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 8.09 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 14.14 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 14.39 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 5.00 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 2.72 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn | 4.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.66 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 3.53 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 1.83 Mn |